


<PubmedArticle>
    <MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM">
        <PMID Version="1">31198411</PMID>
        <DateRevised>
            <Year>2019</Year>
            <Month>06</Month>
            <Day>14</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Print">1507-1367</ISSN>
                <JournalIssue CitedMedium="Print">
                    <Volume>24</Volume>
                    <Issue>4</Issue>
                    <PubDate>
                        <MedlineDate>2019 Jul-Aug</MedlineDate>
                    </PubDate>
                </JournalIssue>
                <Title>Reports of practical oncology and radiotherapy : journal of Greatpoland Cancer Center in Poznan and Polish Society of Radiation Oncology</Title>
                <ISOAbbreviation>Rep Pract Oncol Radiother</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Patients' view of the differences in topical creams for radiation dermatitis prevention. A pilot study of cosmetic properties.</ArticleTitle>
            <Pagination>
                <MedlinePgn>347-354</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.rpor.2019.03.006</ELocationID>
            <Abstract>
                <AbstractText Label="Aim" NlmCategory="UNASSIGNED">To investigate the feasibility of including patients' reports on the cosmetic properties of topical formulations for acute radiation dermatitis (ARD).</AbstractText>
                <AbstractText Label="Background" NlmCategory="UNASSIGNED">No topical agent tested for acute radiation dermatitis (ARD) has proven to be better than any other, all achieving similar objective outcomes. No clear guidelines have therefore been established in clinics. Because the vehicle for such creams has shown to be an important factor in patient adherence to treatments in other dermatological diseases, patients' opinions are evaluated.</AbstractText>
                <AbstractText Label="Material and methods" NlmCategory="UNASSIGNED">Seventy breast cancer patients referred for postoperative radiotherapy after conservative surgery were enrolled. Patients were assigned to use one of the 7 topical agents that are most-commonly used in the prevention of ARD. Patients' reports were assessed using continuous visual analogue scales (VAS), objective signs and symptoms produced by ARD, and were rated using the RTOG and RISRAS scales.</AbstractText>
                <AbstractText Label="Results" NlmCategory="UNASSIGNED">The creams tested differed in their cosmetic properties significantly (<i>p</i> = 0.044). The performance of the agent, their absorption and any residue left over were also significantly different (<i>p</i> = 0.022, 0.014 and 0.02, respectively).</AbstractText>
                <AbstractText Label="Conclusions" NlmCategory="UNASSIGNED">Topical agents for preventive ARD are reported by patients to show different cosmetic properties. Cosmetic properties are important when choosing topical agents for ARD prevention. Recommending those with better cosmetic profiles would improve patient adherence to treatments.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Sabater</LastName>
                    <ForeName>Sebastia</ForeName>
                    <Initials>S</Initials>
                    <AffiliationInfo>
                        <Affiliation>Dpt of Radiation Oncology, Complejo Hospitalario Universitario de Albacete (CHUA), C/Hnos Falcó 37, Albacete 02006, Spain.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Leon</LastName>
                    <ForeName>Rafael</ForeName>
                    <Initials>R</Initials>
                    <AffiliationInfo>
                        <Affiliation>Dpt of Radiation Oncology, Hospital Universitari Sant Joan de Reus, Av. del Dr. Josep Laporte, 2, Reus 43204, Spain.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Esteban</LastName>
                    <ForeName>Cesar</ForeName>
                    <Initials>C</Initials>
                    <AffiliationInfo>
                        <Affiliation>Dpt of Radiation Oncology, Hospital Universitari Sant Joan de Reus, Av. del Dr. Josep Laporte, 2, Reus 43204, Spain.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Añon</LastName>
                    <ForeName>Jose Luis</ForeName>
                    <Initials>JL</Initials>
                    <AffiliationInfo>
                        <Affiliation>Dpt of Radiation Oncology, Hospital Universitari Sant Joan de Reus, Av. del Dr. Josep Laporte, 2, Reus 43204, Spain.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Arenas</LastName>
                    <ForeName>Meritxell</ForeName>
                    <Initials>M</Initials>
                    <AffiliationInfo>
                        <Affiliation>Dpt of Radiation Oncology, Hospital Universitari Sant Joan de Reus, Av. del Dr. Josep Laporte, 2, Reus 43204, Spain.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2019</Year>
                <Month>06</Month>
                <Day>06</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>Netherlands</Country>
            <MedlineTA>Rep Pract Oncol Radiother</MedlineTA>
            <NlmUniqueID>100885761</NlmUniqueID>
            <ISSNLinking>1507-1367</ISSNLinking>
        </MedlineJournalInfo>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">ARD, acute radiation dermatitis</Keyword>
            <Keyword MajorTopicYN="N">CTCAE, Common Terminology Criteria for Adverse Events</Keyword>
            <Keyword MajorTopicYN="N">Cosmetic properties</Keyword>
            <Keyword MajorTopicYN="N">Patient-reported outcomes</Keyword>
            <Keyword MajorTopicYN="N">QoL, quality of life</Keyword>
            <Keyword MajorTopicYN="N">RISRAS</Keyword>
            <Keyword MajorTopicYN="N">RISRAS, Radiation-Induced Skin Reaction Assessment Scale</Keyword>
            <Keyword MajorTopicYN="N">RT, radiation therapy</Keyword>
            <Keyword MajorTopicYN="N">RTOG</Keyword>
            <Keyword MajorTopicYN="N">RTOG, Radiation Therapy Oncology Group</Keyword>
            <Keyword MajorTopicYN="N">Radiation dermatitis</Keyword>
            <Keyword MajorTopicYN="N">Radiotherapy</Keyword>
            <Keyword MajorTopicYN="N">STAT, Skin toxicity assessment tool</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2018</Year>
                <Month>03</Month>
                <Day>16</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2018</Year>
                <Month>12</Month>
                <Day>18</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2019</Year>
                <Month>03</Month>
                <Day>20</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pmc-release">
                <Year>2020</Year>
                <Month>07</Month>
                <Day>01</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2019</Year>
                <Month>6</Month>
                <Day>15</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2019</Year>
                <Month>6</Month>
                <Day>15</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2019</Year>
                <Month>6</Month>
                <Day>15</Day>
                <Hour>6</Hour>
                <Minute>1</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">31198411</ArticleId>
            <ArticleId IdType="doi">10.1016/j.rpor.2019.03.006</ArticleId>
            <ArticleId IdType="pii">S1507-1367(19)30034-3</ArticleId>
            <ArticleId IdType="pmc">PMC6556740</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>

